Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Alain Latil"'
Autor:
Myriem Otmani Idrissi, Jean-Pierre Baudoin, Anne-Line Chateau, Sarah Aherfi, Marielle Bedotto-Buffet, Alain Latil, Hubert Lepidi, Jacques Chiaroni, Christophe Picard, Jean-Louis Mege, Bernard La Scola, Soraya Mezouar
Publikováno v:
Pathogens, Vol 10, Iss 8, p 934 (2021)
Background: The SARS-CoV-2 pandemic has impacted tissue transplantation procedures since conjunctivas were found to be associated with coronavirus infection. Here, we investigated infection of a cornea graft from a COVID-19-positive donor. Methods: I
Externí odkaz:
https://doaj.org/article/c718bae4bbc94165aca323069ff287bb
Autor:
Grégoire Robert, Alain Latil, Jerome Rouquet, Marie-Thérèse Pétrissans, Alexandre de la Taille
Publikováno v:
The Prostate
Background Chronic prostatic inflammation (CPI) could be a cause of symptomatic or complicated benign prostatic hyperplasia (BPH). In previous in vitro and in vivo studies, Hexanic Extract of Serenoa repens (HESr) namely Permixon® has demonstrated p
Autor:
Alain Latil, Vincent Goffin, Philippe Camparo, Natascha Pigat, Gérard Friedlander, Mélanie Viltard, Sophie Bernichtein
Publikováno v:
The Prostate. 75:706-722
BACKGROUND Permixon®, the hexanic lipidosterolic extract of saw palmetto Serenoa repens (LSESr), has shown properties that highlight its benefit in the management of benign prostate hyperplasia (BPH). To address its actual anti-inflammatory potency,
Autor:
Stefan Pfuhler, R. Fautz, Alain Latil, Kerstin Reisinger, Walter Diembeck, C. Moore, Nicola J. Hewitt, Julia Kenny, João Barroso, Gladys Ouedraogo
Publikováno v:
Toxicology in Vitro. 28(1):18-23
The Cosmetics Europe (formerly COLIPA) Genotoxicity Task Force has driven and funded three projects to help address the high rate of misleading positives in in vitro genotoxicity tests: The completed “False Positives” project optimized current ma
Use of Human In Vitro Skin Models for Accurate and Ethical Risk Assessment: Metabolic Considerations
Autor:
Ellen Fritsche, Joan Eilstein, Alain Latil, Carsten Goebel, João Barroso, Gladys Ouedraogo, Claire Moore, Daniel Duche, Kerstin Reisinger, Stefan Pfuhler, Pierre Aeby, Julia Kenny, Jochen Kuehnl, Robert Edwards, Nicola J. Hewitt, Julia Scheel, Rolf Fautz
Publikováno v:
Toxicological Sciences. 133:209-217
Several human skin models employing primary cells and immortalized cell lines used as monocultures or combined to produce reconstituted 3D skin constructs have been developed. Furthermore, these models have been included in European genotoxicity and
Autor:
Thien Ngoc Nguyen, Alain Latil, Christine Libon, Marie Templier, Didier Junquero, Frédérique Lantoine-Adam
Publikováno v:
BJU International. 110:E301-E307
What's known on the subject? and What does the study add? Pervasive inflammatory infiltrates, mainly composed of chronically activated T cells and monocytes/macrophages, have been observed in benign prostatic hyperplasia (BPH). Permixon®, a hexanic
Autor:
Alain Houlgatte, Karine Chantrel-Groussard, Pierre Teillac, S. Guimard, Philippe Berthon, R. Thuret, Alain Latil, Abdel-Rahmène Azzouzi, Olivier Cussenot, Jean-Marie Villette
Publikováno v:
British Journal of Cancer
We investigated whether genetic lesions such as loss of heterozygosity (LOH) are detected in prostatic cells obtained by prostatic massage during early diagnosis of prostate cancer (CaP) and discussed their clinical relevance. Blood and first urine v
Autor:
Ivan Bièche, Gaëlle Fromont, Guy Vallancien, Philippe Mangin, Michel Vidaud, Pierre Validire, Olivier Cussenot, Georges Fournier, Alain Latil, Laurent Chene
Publikováno v:
Journal of Urology. 172:1382-1385
Benign prostatic hyperplasia (BPH) is characterized by a hyperplastic growth of epithelial and stromal cells in the prostate. Despite the high prevalence of the disease little is known regarding the molecular etiology of BPH. Therefore, a comparison
Autor:
Philippe Berthon, Alain Latil, Laurent Boccon-Gibod, Christiane Giroud, François Desgrandchamps, Laurent Chene, Olivier Cussenot
Publikováno v:
International Journal of Cancer. 111:798-804
Loss of heterozygosity (LOH) on chromosome arm 7q31 is found in many prostate tumors. Such alterations are generally associated with inactivation of tumor suppressor genes. It has been shown previously that the main region of LOH at 7q31 spans the in
Autor:
Karine Chantrel-Groussard, B. Guillonneau, Vincent Joulin, Guy Vallancien, Alain Latil, Pierre Validire, Olivier Cussenot, Gaëlle Fromont
Publikováno v:
Journal of Urology. 170:1394-1397
Loss of heterozygosity (LOH) is the most consistent genetic alteration in prostate cancer (CaP), frequently associated with advanced cancer and metastasis. We performed LOH analysis on 6 chromosomal regions of interest in localized CaP to obtain an o